ANDA 76136, held by Teva. Ciprofloxacin Hydrochloride.
As of Nov 15, 2026, ANDA 76136 (Ciprofloxacin Hydrochloride), held by Teva, was not approved, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 26, 2001 | Original application | Tentative approval |
| Ciprofloxacin HydrochlorideEQ 250MG BASE · tablet;oral | Ciprofloxacin Hydrochloride | Discontinued |
| Ciprofloxacin HydrochlorideEQ 500MG BASE · tablet;oral | Ciprofloxacin Hydrochloride | Discontinued |
| Ciprofloxacin HydrochlorideEQ 750MG BASE · tablet;oral | Ciprofloxacin Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
